REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 27 filers reported holding REGULUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 4,263,701 | $7,610,706 | 1.20% |
| Vivo Capital, LLC | 5,000,000 | $8,925,000 | 0.82% |
| CVI Holdings, LLC | 401,012 | $715,806 | 0.62% |
| Opaleye Management Inc. | 1,475,000 | $2,632,875 | 0.60% |
| DAFNA Capital Management LLC | 895,200 | $1,597,932 | 0.38% |
| Deep Track Capital, LP | 3,262,564 | $5,823,677 | 0.17% |
| RA Capital Management | 6,250,000 | $11,156,250 | 0.15% |
| Sarissa Capital Management LP | 185,183 | $330,552 | 0.06% |
| FEDERATED HERMES, INC. | 12,852,654 | $22,941,988 | 0.05% |
| Monashee Investment Management LLC | 197,049 | $351,732 | 0.04% |